Pfizer (BOG:PFECO) Cyclically Adjusted PB Ratio: (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOG:PFECO Pfizer Inc BOG:PFECO
70 GF Score
Price COP95,840.00
GF Value COP99,518.78
! 5 Warning Signs
View Full Analysis

What is Pfizer Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer  (BOG:PFECO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pfizer Cyclically Adjusted PB Ratio Related Terms


Pfizer Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Pfizer's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cyclically Adjusted PB Ratio Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.58 3.69 1.98 1.77 1.61

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 1.58 1.65 1.61 1.78

BOG:PFECO vs BMY, GILD, AMGN: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.


BOG:PFECO
70GF Score
Pfizer Inc BOG:PFECO
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=58105.416/330.2130*330.2130
=58,105.416

Current CPI (Mar. 2026) = 330.2130.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201606 32,190.984 241.018 44,104.098
201609 30,398.756 241.428 41,577.880
201612 30,130.160 241.432 41,209.825
201703 28,296.409 243.801 38,325.692
201706 29,866.330 244.955 40,261.478
201709 29,983.223 246.819 40,113.808
201712 35,938.828 246.524 48,139.200
201803 33,933.937 249.554 44,901.813
201806 34,372.599 251.989 45,042.756
201809 37,562.108 252.439 49,134.628
201812 35,829.689 251.233 47,093.451
201903 32,575.639 254.202 42,316.345
201906 36,124.004 256.143 46,570.141
201909 39,914.723 256.759 51,333.587
201912 40,048.165 256.974 51,462.112
202003 40,984.823 258.115 52,432.913
202006 43,160.958 257.797 55,285.009
202009 43,389.544 260.280 55,047.608
202012 40,484.467 260.474 51,323.730
202103 44,488.429 264.877 55,462.187
202106 45,958.264 271.696 55,856.605
202109 50,649.433 274.310 60,971.533
202112 54,139.611 278.802 64,122.938
202203 57,876.943 287.504 66,474.619
202206 58,802.634 296.311 65,530.453
202209 73,169.747 296.808 81,404.819
202212 81,239.293 296.797 90,385.923
202303 86,464.199 301.836 94,593.099
202306 77,781.733 305.109 84,181.520
202309 69,616.680 307.789 74,688.611
202312 63,147.444 306.746 67,978.415
202403 63,926.656 312.332 67,586.456
202406 59,648.652 314.175 62,693.595
202409 68,021.276 315.301 71,238.308
202412 69,010.448 315.605 72,204.645
202503 65,561.863 319.799 67,696.833
202506 62,955.187 322.561 64,448.651
202509 63,966.917 324.800 65,032.967
202512 56,887.094 324.054 57,968.295
202603 58,105.416 330.213 58,105.416

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Pfizer (BOG:PFECO) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of COP95,840.00 is trading 3.7% below its estimated GF Value™ of COP99,518.78.

Key valuation signals for BOG:PFECO:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: COP99,518.78 vs. price of COP95,840.00 (3.7% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BOG:PFECO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
70GF Score

Get the complete analysis for BOG:PFECO

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

COP95,840.00
Price
COP99,518.78
GF Value